Related references
Note: Only part of the references are listed.Arteritis after administration of granulocyte colony-stimulating factor: a case series
Ken Sasaki et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
G-CSF-induced aortitis: Two cases and review of the literature
Ioannis Parodis et al.
AUTOIMMUNITY REVIEWS (2019)
Granulocyte colony-stimulating factor-associated aortitis in the Japanese Adverse Drug Event Report database
Yasuo Oshima et al.
CYTOKINE (2019)
Acute arteritis after G-CSF administration
Yasuyuki Kinjo et al.
INTERNATIONAL CANCER CONFERENCE JOURNAL (2019)
Drug-induced large vessel vasculitis with carotid arterial ring sign
S. Fukui et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2018)
Drug-induced aortitis in a patient with ovarian cancer treated with bevacizumab combination therapy
Kengo Hiranuma et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2018)
Thoracic aortitis and aortic dissection following pegfilgrastim administration
Yuki Sato et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2017)
Myeloid Growth Factors, Version 2.2017 Clinical Practice Guidelines in Oncology
Jeffrey Crawford et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Isolated abdominal aortitis following administration of granulocyte colony stimulating factor (G-CSF)
Edward B. Miller et al.
CLINICAL RHEUMATOLOGY (2016)
Giant Cell Arteritis which Developed after the Administration of Granulocyte-colony Stimulating Factor for Cyclic Neutropenia
Masataka Umeda et al.
INTERNAL MEDICINE (2016)
Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy
Chang Gon Kim et al.
JOURNAL OF BREAST CANCER (2016)
Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer
Hyo Sook Han et al.
EUROPEAN JOURNAL OF CANCER (2011)
Changes of cytokine levels during granulocyte-colony-stimulating factor stem cell mobilization in healthy donors: association with mobilization efficiency and potential predictive significance
Daniel Lysak et al.
TRANSFUSION (2011)
Abdominal Aortitis after Use of Granulocyte Colony-Stimulating Factor
Giridhar U. Adiga et al.
CLINICAL DRUG INVESTIGATION (2009)
Review article: Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
Ying Gao et al.
NEPHROLOGY (2009)
GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival
Ivo Sonderegger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Granulocyte Colony–Stimulating Factor Administration: Adverse Events
Anita D'Souza et al.
TRANSFUSION MEDICINE REVIEWS (2008)
Aortitis after G-CSF injections
C Darie et al.
REVUE DE MEDECINE INTERNE (2004)
Spontaneous splenic rupture with fatal outcome following G-CSF administration for myelodysplastic syndrome
DP O'Malley et al.
AMERICAN JOURNAL OF HEMATOLOGY (2003)
Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphoma
JM Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 multicenter phase III trial
L Biganzoli et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer
FA Holmes et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Fatal pulmonary toxicity related to the administration of granulocyte colony-stimulating factor in amyloidosis: A report and review of growth factor-induced pulmonary toxicity
MA Gertz et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2000)
Share Paper
